What's new in tocolytics

M. R. Leonardi, G. D.V. Hankins

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Tocolytic therapy represents the final obstetric end point in the prevention of premature births. For the past two decades, betamimetic therapy has been the mainstay of tocolytic therapy. Newer agents, indomethacin and nifedipine, offer new hope in the treatment of premature labor. With the introduction of these newer agents, combination drug therapy appears to be on the horizon.

Original languageEnglish (US)
Pages (from-to)367-384
Number of pages18
JournalClinics in Perinatology
Issue number2
StatePublished - 1992
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'What's new in tocolytics'. Together they form a unique fingerprint.

Cite this